Documents

Federal rules and notices from the public comment record, analyzed continuously.

FDAOther

Suitability Petition from Quagen Pharma LLC

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Suitability Petition from Quagen Pharma LLC

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Citizen Petition from Joseph Goldman

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Citizen Petition from Jhon Jairo Antonio Martinez Alvarez

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Citizen Petition from Primus Pharmaceuticals, Inc.

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Citizen Petition from The Food Foundations Project

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Citizen Petition from Age Reversal Unity

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Suitability Petition from Pharmobedient Consulting, LLC

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDANotice

Agency Information Collection Activities; Proposed Collection; Comment Request; Potential Tobacco Product Violations Reporting Form

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Aug 25
FDANotice

Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Aug 25
FDANotice

Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Aug 26
FDANotice

Determination of Regulatory Review Period for Purposes of Patent Extension; VYALEV

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Aug 29